182 related articles for article (PubMed ID: 7911140)
1. Serotonin receptor responsivity in schizophrenia.
Kahn RS; Davidson M
Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():47-51. PubMed ID: 7911140
[No Abstract] [Full Text] [Related]
2. Pharmacotherapy of schizophrenia: a review.
Sigmundson HK
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S70-5. PubMed ID: 7533053
[TBL] [Abstract][Full Text] [Related]
3. The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research.
Kerwin RW
Br J Psychiatry; 1994 Feb; 164(2):141-8. PubMed ID: 7513599
[No Abstract] [Full Text] [Related]
4. [Dopamine D2 and serotonin 5HT2 receptors: functions, interactions and clinical consequences in schizophrenia].
Guise S; Soubrouillard C; Blin O
Encephale; 1997 Apr; 23 Spec No 2():10-6. PubMed ID: 9273300
[TBL] [Abstract][Full Text] [Related]
5. Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia.
Seibyl JP
J Psychopharmacol; 1997; 11(2):188-9. PubMed ID: 9208382
[No Abstract] [Full Text] [Related]
6. [Neuroleptics and serotonin].
Hery F; Hamon M
Encephale; 1993; 19(5):525-32. PubMed ID: 7905821
[TBL] [Abstract][Full Text] [Related]
7. Acute tryptophan depletion in schizophrenic patients treated with clozapine.
George TP; Potenza MN; Degen K; Sernyak MJ; Woods S; McDougle CJ
Arch Gen Psychiatry; 2002 Mar; 59(3):291-2. PubMed ID: 11879174
[No Abstract] [Full Text] [Related]
8. Effect of adjunctive treatment with serotonin-1A agonist tandospirone on memory functions in schizophrenia.
Sumiyoshi T; Matsui M; Yamashita I; Nohara S; Uehara T; Kurachi M; Meltzer HY
J Clin Psychopharmacol; 2000 Jun; 20(3):386-8. PubMed ID: 10831031
[No Abstract] [Full Text] [Related]
9. Pathophysiology and treatment of negative symptoms.
Villeneuve A
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S53-8. PubMed ID: 7533052
[TBL] [Abstract][Full Text] [Related]
10. The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice.
Stahl SM; Shayegan DK
J Clin Psychiatry; 2003; 64 Suppl 19():6-12. PubMed ID: 14728084
[TBL] [Abstract][Full Text] [Related]
11. [Psychopharmacologic approaches to schizophrenic psychoses].
Giacardy-Paty M; Soubrouillard C; Blin O
Encephale; 1995 Jun; 21 Spec No 3():3-8. PubMed ID: 7628339
[TBL] [Abstract][Full Text] [Related]
12. Ziprasidone augmentation of clozapine in 11 patients.
Kaye NS
J Clin Psychiatry; 2003 Feb; 64(2):215-6. PubMed ID: 12633133
[No Abstract] [Full Text] [Related]
13. Novel neuroleptics in schizophrenia: theory and clinical relevance.
Remington GJ
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S43-5. PubMed ID: 7533050
[No Abstract] [Full Text] [Related]
14. Clozapine augmented with aripiprazole in 5 patients with schizophrenia.
Abu-Tair F; Kopitz J; Bergemann N
J Clin Psychopharmacol; 2006 Dec; 26(6):669-71. PubMed ID: 17110831
[No Abstract] [Full Text] [Related]
15. Heterogeneity of serotonergic response in treatment-refractory schizophrenia patients.
Lindenmayer JP; Adityanjee ; Vital-Herne M; Bark N; Grochowski S; Moynihan N
Biol Psychiatry; 1997 Jul; 42(1):6-12. PubMed ID: 9193736
[TBL] [Abstract][Full Text] [Related]
16. Clozapine augmentation with aripiprazole for negative symptoms.
Clarke LA; Lindenmayer JP; Kaushik S
J Clin Psychiatry; 2006 Apr; 67(4):675-6. PubMed ID: 16669737
[No Abstract] [Full Text] [Related]
17. [Clinical psychopharmacology: the example of clozapine (Leponex)].
Péré JJ
Encephale; 1995 Jun; 21 Spec No 3():9-12. PubMed ID: 7628347
[TBL] [Abstract][Full Text] [Related]
18. Towards more effective antipsychotic treatment.
Kane JM; Freeman HL
Br J Psychiatry Suppl; 1994 Nov; (25):22-31. PubMed ID: 7865194
[TBL] [Abstract][Full Text] [Related]
19. [Weight gain and clozapine].
Jalenques I; Tauveron I; Albuisson E; Audy V
Encephale; 1996 Oct; 22 Spec No 3():77-9. PubMed ID: 8954282
[No Abstract] [Full Text] [Related]
20. The D2 receptor: love it and leave it.
Pickar D
Mol Psychiatry; 1998 Mar; 3(2):101-2. PubMed ID: 9577830
[No Abstract] [Full Text] [Related]
[Next] [New Search]
